LUPUS, vol.27, no.9, pp.1509-1516, 2018 (Journal Indexed in SCI)
Aim To assess subclinical atherosclerosis and the role of inflammatory mediators, vascular endothelial cell activation markers and adipocytokines in systemic lupus erythematosus (SLE) in the presence or absence of metabolic syndrome (MetS).